for more information about stanelco click on the links.

driver's research page link
http://www.moneyam.com/InvestorsRoom/posts.php?tid=7681#lastread
website link
http://www.stanelco.co.uk/index.htm

rf
When youre in you ramp when youre out you deramp very constructive Not. I suggest you keep your predictions to yourself unless you see it going to a 1 in witch case you will properly be out any way.

"if this company gets this right this year you could see it above 2p I think.."

"I fear this is diving to below .5p !"

"I fear that this is going back to the .2p"

Oblo,

The very next para mentioned something about "the Novamont licene agreement" but I've not yet looked deeper into it.

Biotec sales are and will increase, so inevitably a break-even point will be reached...unless SEO keep piling on the exceptionals!

Thanks gary - take a look at these - it would appear that Biotec signed away exclusive use of their patents to Novamont.

http://www.materbi.com/ing/html/allegato.php?tipo=comunicato&id=35



http://www.allbusiness.com/legal/civil-procedure-settlement-compromise/6107524-1.html

http://findarticles.com/p/articles/mi_m0EIN/is_2001_August_3/ai_76952518

This is for the U.S.

http://contracts.onecle.com/earthshell/biotec.lic.2002.07.29.shtml

This from the 2006 prospectus:-

'At Closing, the Seller released all its rights under any agreements where the Biotec Entities are the principal
contracting party, including the Licence and the Novamont Licence Agreement (as defined below) and the
Biotec Entities performed the obligations of the Seller under such agreements to the extent not subsequently
released. The Company agreed to indemnify the Seller for any failure by the Biotec Entities to perform the
obligations of the Seller under such agreements.'

Is the agreement still in force? Maybe Novamont think it is!

SEO remain an enigma as far as I'm concerned: on the one hand they say:-

"Our BioPlastics division encompasses all our activities in bio-based plastics.We have grouped together in this division Aquasol, the Biotec JV and our business based on growing sales of bioplastics, either based on Biotec's IP or on IP offering similar advantages in the marketplace. We regard this as our core business going forward and are looking for new opportunities to increase its critical mass quickly."

Then they say:-

"Whilst we believe the existing product offering is 'best-in-class' versus
competitive biomaterials, the functional attributes often fall far short of
existing oil based products (backed, as they are, by decades of development)."

What the f***??!

I wish I could go to the AGM, I'd take more than a sharpened stick!!

Well said DRIVER.
Theres been an awful lot of pants and faces from the past surfacing to pump/ridicule/dump etc.

I've made a few quid with the rise but I want to see 2p and still believe this company has the necessary legs to reach it. It is'nt going to be overnight, but slowly slowly catchey monkey.

The sp rise/fall over past few days was way OTT , as per usual on hype and no substance.
THERE ARTE NO NEW CONTRACTS, PATENT DISPUTE STILL OUTSTANDING etc.
So the only thing thats changed is the losses have been reduced. The management have stated that they expect developments THIS YEAR.
So I'll give them a chance. Like TWEENIE I'll be at the AGM to make my voice heard and will expect suitable development, not just empty gestures.
All in all the results were exactly what i expected- as I suspect was the case for most genuine LT holders on this site.
Anyone who got burnt should have known better than to believe the hype and anyone who was ramping was only in it for themselves for a small gain.
No names mentioned, but you know who you are.
anyway. Enough rambling. shares tucked away for another year.
await NEWS
await directers buying shares.
lets hope it is'nt in vain.

I don't think you'll wait in vain, WD.
When I first bought in, the tip came from someone who qualified it by saying, put them in a drawer and let your grandkids thank you for it.
My regret is I bought in too early and I am too stupid to forget about them.
We are used to a diet of massive contract promises and huge sales potential, and we are naturally disappointed by the results. But as you say, deep down we expected no other.
If you were nuetral, you may look at these results and think the company had slashed cash burn, was slowly increasing turnover, was a partner in a business that is observably growing, has plans to recruit more staff to cope with expected increase in demand, has enough cash to stay liquid for some considerable time, is in discussions with customers who are interested and has an old established product stream to fall back on if things are just too slow.
On the negative side it is losing money and has a product that has its problems from the customers perspective, its patents are being challanged and the market looks to become more competative than ever.
I am happy with my holding and the position at the moment. Of course I'd like answers, and I will not get them. I'd like an announcement that the whole world is buying into Biotec, but I won't get that either. What I think we will get is proper trials with real retailers this year, one or two orders and a good increase in Biotec sales through SPhere and others.
Perhaps if the SP had advanced from 0.2 to 0.6 AFTER the results, we would all have read them differently.
Anyway, what do I care? Its your brass, all of you, and it doesn't make the slightest difference to me whether you are in or out. But I'll stay in for some time yet. I'm just not ready to increase.
Alan

Sphere are looking to suppliers other than Biotec for their bioplastics - doesn't give me much confidence that Novamont's claims are unfounded.

SEO may be confident the dispute will be settled (in a year or two, they say!), but Sphere are obviously less confident or they'd still be using Biotec.

In response to driver's moans....this stock moves up or down on a nothing rumour... I'm just trying to guess which way this bleated stock will go....could be .2p.... or on a whim of buying it could go up to 1p or more...could be over 2p at the end of the year....like many other people I,m trying to make a buck or two...I feel sorry for those that have bought in at 10p plus and are still in but with the stockmarket things move fast...making any sense out of this company takes some doing....at the moment I'd say things do not look promising !

PS. wonderful spelling the lot of you...really spot on !

required field - 16 Mar 2008 10:11 - 26220 of 26220

PS. wonderful spelling the lot of you...really spot on !


Nice grrrrrrammer and punchuation. glassssshoses abnd all dat.
:-)

tweenie , thanks ! I make mistakes as well....but there is a limit...reading through some of the other bloggers...please check spelling before blogging if possible ! by the way how's the bottle of wine... ? or beer ? or spirits possibly ?

rf - You have a tendency to omit the capital letter at the beginning of your sentences - hanging offence in my opinion!

RF, Tolerance is a marvelous attribute!

This is from somebody who was/is dyslexic.

Oblo,

Re: post 26218, you state that "Sphere are looking to suppliers other than Biotec for their bioplastics" where did you get that from?

Everybody...SEO can wait.... check out AEX this morning !

garyble,

From the prelims on Friday (4th para under Strategy)-

'Inevitably, this has caused SPhere to reduce the
volume purchased from Biotec somewhat.'

http://production.investis.com/seo/regnews/rnsitem?id=1205478154nRNSN0977Q

I assume from that they're getting what they need elsewhere - they wouldn't stop production until the patent dispute with Novamont is settled (1 or 2 years at the least) , would they?

Also from the prelims - 'We are advised that the proceedings are at an early stage and a judgment is not expected for a year or two at least.'


Thats what I meant by saying the patents dispute would finish SEO off - 2 years at least during which Sphere will go elsewhere and possibly set up arrangements they'll stay with after the dispute is settled. Biotec could be fatally injured by this dispute. IMO, whether in the right or not.

And during that period the promissory notes may come home to roost! Biotec will need something to keep them afloat, Sphere may want SEO to settle the debt to help do that.

Thanks Oblo,

Certainly worst case scenario and good to have that as a reasonably possible outcome.

From past performance {BPRG CC} SEO were very upbeat with their "defend rigorously" etc, ect.... Then had to pay 1m plus share the patent(s), so I'm not at all confident about this current patent dispute with Novamont.

Can't they get it right?:

http://www.packagingnews.co.uk/news/790880/Stanelco-results-hit-project-closure/

"The company's share price fell 11p to reach 68p following the results announcement"...we wish!

after reading RF's post , i sold all my SEO stock and brought into AEX.

He's my hero.

;-)



A lot of panic selling early door,lets see what this week has in store.

Well advised tweenie...AEX will do well !